Phillip R. Fleshner
Distinguished in Small Bowel Resection

Dr. Phillip R. Fleshner

Colorectal Surgery
8737 Beverly Blvd, 
West Hollywood, CA 
Distinguished in Small Bowel Resection
8737 Beverly Blvd, 
West Hollywood, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Phillip Fleshner is a Colorectal Surgeon in West Hollywood, California. Dr. Fleshner is rated as a Distinguished provider by MediFind in Small Bowel Resection. His top areas of expertise are Crohn's Disease, Ulcerative Colitis, Viral Gastroenteritis, Ileostomy, and Small Bowel Resection.

His clinical research consists of co-authoring 153 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Small Bowel Resection.

Specialties
Colorectal Surgery
Licenses
Colon & Rectal Surgery in CA
Hospital Affiliations
Cedars-Sinai Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

8737 Beverly Blvd, West Hollywood, CA 90048

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Biological, Other
Study Drug: Darvadstrocel Adipose Stem Cell Transplantation
Study Phase: Phase 3
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large- and Small-Bowel Resection
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large- and Small-Bowel Resection
Enrollment Status: Completed
Publish Date: June 23, 2023
Intervention Type: Drug
Study Phase: Phase 2
Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic
Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic
Enrollment Status: Completed
Publish Date: December 27, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
Prospective Randomized Controlled Trial Investigating Commencement of Low Residue Diet Versus Clear Liquids on Postoperative Zero Following Elective Colorectal Surgery
Prospective Randomized Controlled Trial Investigating Commencement of Low Residue Diet Versus Clear Liquids on Postoperative Zero Following Elective Colorectal Surgery
Enrollment Status: Completed
Publish Date: January 31, 2020
Intervention Type: Device, Dietary supplement
Study Phase: Not Applicable
Prospective Randomized Control Study on Effect of Post Operative Loperamide in Decreasing Readmission for Dehydration in Colorectal Patients After Diverting Ileostomies
Prospective Randomized Control Study on Effect of Post Operative Loperamide in Decreasing Readmission for Dehydration in Colorectal Patients After Diverting Ileostomies
Enrollment Status: Terminated
Publish Date: December 20, 2017
Intervention Type: Drug
Study Phase: Phase 3
Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Post-Operative Infection I
Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Post-Operative Infection I
Enrollment Status: Completed
Publish Date: September 13, 2017
View 6 Less Clinical Trials

153 Total Publications

Evaluation of TU-100 (Daikenchuto), a Traditional Japanese Kampo Medicine, As an Adjunct to Enhanced Recovery After Surgery, for Acceleration of Gastrointestinal Recovery After Bowel Resection - Results of a Proof-of-Concept, Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.
Evaluation of TU-100 (Daikenchuto), a Traditional Japanese Kampo Medicine, As an Adjunct to Enhanced Recovery After Surgery, for Acceleration of Gastrointestinal Recovery After Bowel Resection - Results of a Proof-of-Concept, Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Diseases of the colon and rectum
Published: October 20, 2025
Similar Doctors
Experienced in Small Bowel Resection
Dr. Alessio Pigazzi
Colorectal Surgery | General Surgery
Experienced in Small Bowel Resection
Dr. Alessio Pigazzi
Colorectal Surgery | General Surgery

City Of Hope Medical Foundation

Irvine, CA 
 (46.8 miles away)
949-671-4673
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Alessio Pigazzi is a Colorectal Surgeon and a General Surgeon in Irvine, California. Dr. Pigazzi is rated as a Distinguished provider by MediFind in Small Bowel Resection. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Ileostomy, and Endoscopy.

Experienced in Small Bowel Resection
Dr. Marcia M. Russell
Colorectal Surgery | General Surgery
Experienced in Small Bowel Resection
Dr. Marcia M. Russell
Colorectal Surgery | General Surgery

UCLA Associated General Surgeons

757 Westwood Plz, Fl 7, 
Los Angeles, CA 
 (3.7 miles away)
310-825-4381
Languages Spoken:
English
See accepted insurances

Marcia Russell is a Colorectal Surgeon and a General Surgeon in Los Angeles, California. Dr. Russell is rated as an Advanced provider by MediFind in Small Bowel Resection. Her top areas of expertise are Hemorrhoids, Gallstones, Colorectal Cancer, Appendectomy, and Small Bowel Resection.

Mark D. Girgis
Advanced in Small Bowel Resection
Dr. Mark D. Girgis
Surgical Oncology | General Surgery | Colorectal Surgery
Advanced in Small Bowel Resection
Dr. Mark D. Girgis
Surgical Oncology | General Surgery | Colorectal Surgery

The Regents Of The University Of California

200 Medical Plaza, Suite 120, 
Los Angeles, CA 
 (3.8 miles away)
310-390-4099
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Girgis is a Surgical Oncologist and a General Surgeon in Los Angeles, California. Dr. Girgis is rated as a Distinguished provider by MediFind in Small Bowel Resection. His top areas of expertise are Pancreatic Cancer, Stomach Cancer, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fleshner's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile